Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 2009, p. 5529-5539, Vol. 29, No. 20
0270-7306/09/$08.00+0 doi:10.1128/MCB.00375-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
B-Independent Survival Pathways in Tumor Necrosis Factor Alpha Signaling
Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan
Received 24 March 2009/ Returned for modification 6 May 2009/ Accepted 10 August 2009
The kinase TAK1, a mitogen-activated protein kinase kinase kinase (MAP3K), has been widely accepted as a key kinase activating NF-
B and MAPKs in tumor necrosis factor alpha (TNF-
) signaling. We have recently reported that TAK1 regulates the transient phosphorylation and endocytosis of epidermal growth factor receptor (EGFR) in a tyrosine kinase activity-independent manner. In the present study, we found that Thr-669 in the juxtamembrane domain and Ser-1046/1047 in the carboxyl-terminal regulatory domain were transiently phosphorylated in response to TNF-
. Experiments using chemical inhibitors and small interfering RNA demonstrated that TNF-
-mediated phosphorylation of Thr-669 and Ser-1046/7 were differently regulated via TAK1-extracellular signal-regulated kinase (ERK) and TAK1-p38 pathways, respectively. In addition, p38, but not ERK, was involved in the endocytosis of EGFR. Surprisingly, modified EGFR was essential to prevent apoptotic cellular responses; however, the EGFR pathway was independent of the NF-
B antiapoptotic pathway. These results demonstrated that TAK1 controls two different signaling pathways, I
B kinase-NF-
B and MAPK-EGFR, leading to the survival of cells exposed to the death signal from the TNF-
receptor.
Published ahead of print on 17 August 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»